Literature DB >> 3533523

Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa.

C Missale, P Liberini, M Memo, M O Carruba, P Spano.   

Abstract

Dopamine (DA) may participate in the control of aldosterone secretion. We report that two different receptors for DA are present in rat adrenal glomerulosa: D-1, associated with stimulation of adenylate cyclase, and D-2, whose action inhibits adenylate cyclase. The adenylate cyclase system was stimulated by DA (EC50, 7.2 microM) and different DA agonists. When the D-1 receptor blocker SCH 23390 was added to the incubation medium, DA elicited a dose-dependent inhibition of adenylate cyclase (IC50, 10 microM); (-)sulpiride specifically blocked this effect. Furthermore, DA blocked angiotensin II-induced aldosterone release from glomerulosa slices in vitro. This effect was prevented by (-)sulpiride, but not by SCH 23390. The results suggest that the D-2 receptor acts to inhibit the cAMP-generating system and may be physiologically involved in the regulation of aldosterone secretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533523     DOI: 10.1210/endo-119-5-2227

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Reversal by the selective D-2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensives.

Authors:  C Lombardi; R De Cotiis; C Spedini; C Missale; M Memo; P F Spano
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.

Authors:  D A Häberle; B Königbauer
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

4.  Humoral effects of metoclopramide and domperidone in normal subjects and in hypertensive patients.

Authors:  G P Bernini; A R Lucarini; F Franchi; A Salvetti
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

5.  Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors.

Authors:  C Lombardi; C Missale; R De Cotiis; C Spedini; G Pizzoccolo; M Memo; A Albertini; P F Spano
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.